There is no shortage of headlines about GLP-1 medications. Originally developed to manage blood sugar levels, these medications are now widely known for promoting weight loss. Alongside their rapid ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...

NBCUniversal's studio unit saw its bottom line drop, driven by a bigger slate, Disney stayed atop the global box office. Plus, a look at Netflix and its optimism post-WBD auction. By Georg Szalai ...

FILE - The Stellantis sign is seen outside the Chrysler Technology Center, Jan. 19, 2021, in Auburn Hills, Mich. Stellantis on April 26, 2023. (AP Photo/Carlos Osorio ...

Paramount Skydance, in the midst of pursuing a acquisition of Warner Bros, Discovery, saw downturns in revenue from TV advertising and distribution in the fourth quarter, which helped to spur a wider ...

UCLA guard Donovan Dent drives past Kylan Boswell, left, and Andrej Stojakovic on his way to a buzzer-beating and game-winning layup as the host Bruins defeated No. 10 Illinois 95-94 in overtime on ...

Automotive and industrial parts distributor Genuine Parts will separate into two independent companies, it said on Tuesday, months after a deal with activist investor Elliott Investment Management.

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

Singapore conglomerate-turned-asset manager Keppel Ltd. reported a drop in annual earnings after losses sustained in an aggressive push to divest assets overshadowed an improvement in its business ...

Bottom-fishing is sexy but brutal. But if that's your game, this battle-tested on-chain indicator may be your North Star for spotting the bitcoin BTC $76,167.30 bear market bottom. This metric, called ...

Pfizer targets 2028 for its first obesity drug approval Company plans to advance more than 20 obesity trials in 2026 RSV vaccine quarterly sales top expectations Feb 3 (Reuters) - Pfizer (PFE.N), ...